Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-26

FDA Approved: TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a generic fixed-dose combination of trandolapril and verapamil hydrochloride (ANDA) from Glenmark Pharmaceuticals for the treatment of hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trandolapril and Verapamil Hydrochloride (trandolapril and verapamil hydrochloride)

Snippet

ORIG AP for TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE)